Grant: Canada Research Chairs
McMaster University
$200,000.00
Ophthalmic Biomaterials and Drug Delivery Systems
FY 2020-21
Summary
Diseases of the eye represent a significant and increasing burden to society. The cost of vision loss in Canada in 2009 was estimated to be $15.8 B; the number of people living with vision loss is currently more than 1M, more than breast cancer, prostate cancer, Alzheimers and Parkinson's disease combined. This number is expected to double over the next 25 years. Not only does eye disease impact the ability to see, it can have a significant effect on quality of life. The ability to effectively deliver drugs has been suggested as the greatest unmet need in ophthalmology. The chair will focus on developing ocular drug delivery materials and surfaces. Using the high throughput synthesis and characterization to generate libraries of materials, Dr. Sheardown will be able to screen large numbers of materials and ultimately develop the next generation of ophthalmic materials.
Program
Canada Research Chairs
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
1000230480
Name nom
Sheardown, Heather
Department département
Chemical Engineering/Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2014
Award amount
200000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
0
Nb partie
0
Application title
Ophthalmic Biomaterials and Drug Delivery Systems
Keyword
NSERC
Application summary
Diseases of the eye represent a significant and increasing burden to society. The cost of vision loss in Canada in 2009 was estimated to be $15.8 B; the number of people living with vision loss is currently more than 1M, more than breast cancer, prostate cancer, Alzheimers and Parkinson's disease combined. This number is expected to double over the next 25 years. Not only does eye disease impact the ability to see, it can have a significant effect on quality of life. The ability to effectively deliver drugs has been suggested as the greatest unmet need in ophthalmology. The chair will focus on developing ocular drug delivery materials and surfaces. Using the high throughput synthesis and characterization to generate libraries of materials, Dr. Sheardown will be able to screen large numbers of materials and ultimately develop the next generation of ophthalmic materials.